Treatment success rate for patients treated for MDR-TB in Serbia
Serbia: Treatment success rate for patients treated for MDR-TB was 100.0% in 2022. ▲ Rising
Treatment success rate for patients treated for MDR-TB in Serbia, 2009–2022
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for treatment success rate for patients treated for mdr-tb in Serbia is 100.0%, measured in 2022. That is the highest value across all 12 years on record.
The figure is up 100.0% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Serbia peaked at 100.0% in 2020 and was at its lowest, 50.0%, in 2012.
That places Serbia 1st out of 163 countries with data for 2022, putting it in the top 10%.
The long-run direction has been consistently rising across the 12 years of available data.
Treatment success rate for patients treated for MDR-TB in Serbia, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 60.0% | — |
| 2010 | 80.0% | +33.3% |
| 2011 | 64.0% | -20.0% |
| 2012 | 50.0% | -21.9% |
| 2013 | 77.0% | +54.0% |
| 2014 | 54.0% | -29.9% |
| 2015 | 80.0% | +48.1% |
| 2016 | 70.0% | -12.5% |
| 2017 | 67.0% | -4.3% |
| 2020 | 100.0% | +49.3% |
| 2021 | 100.0% | +0.0% |
| 2022 | 100.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 60.0% | 60.0% | 60.0% | 1 |
| 2010s | 67.8% | 50.0% | 80.0% | 8 |
| 2020s | 100.0% | 100.0% | 100.0% | 3 |
Countries ranked near Serbia
- 1 New Zealand 100.0% compare
- 1 Sao Tome and Principe 100.0% compare
- 1 Jordan 100.0% compare
- 1 Kuwait 100.0% compare
- 1 Belize 100.0% compare
- 1 Macau, China 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Montenegro 100.0% compare
- 1 Bahamas 100.0% compare
- 1 Kiribati 100.0% compare
- 1 Cape Verde 100.0% compare
- 1 Puerto Rico 100.0% compare
- 1 Costa Rica 100.0% compare
- 1 Micronesia, Federated States of 100.0% compare
- 1 United Arab Emirates 100.0% compare
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,502 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Population ages 15-19, male, annual growth rate -0.9083 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0249 units per person (2025)
- Population ages 20-24, female, annual growth rate -0.457 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0263 units per person (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Serbia?
- Treatment success rate for patients treated for mdr-tb in Serbia was 100.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Serbia?
- The highest recorded value was 100.0% in 2020.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Serbia?
- The lowest recorded value was 50.0% in 2012.
- How does Serbia rank for treatment success rate for patients treated for mdr-tb?
- Serbia ranks 1st out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Serbia?
- Over the last ten years it is up 100.0%. The long-run trend across the full record is rising.
- Where does this Serbia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 12 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).